Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
- PMID: 16893904
- DOI: 10.1093/hmg/ddl210
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Abstract
Huntington's disease (HD) is a progressive neurodegenerative disorder for which only symptomatic treatments of limited effectiveness are available. Preventing early misfolding steps and thereby aggregation of the polyglutamine (polyQ)-containing protein huntingtin (htt) in neurons of patients may represent an attractive therapeutic strategy to postpone the onset and progression of HD. Here, we demonstrate that the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) potently inhibits the aggregation of mutant htt exon 1 protein in a dose-dependent manner. Dot-blot assays and atomic force microscopy studies revealed that EGCG modulates misfolding and oligomerization of mutant htt exon 1 protein in vitro, indicating that it interferes with very early events in the aggregation process. Also, EGCG significantly reduced polyQ-mediated htt protein aggregation and cytotoxicity in an yeast model of HD. When EGCG was fed to transgenic HD flies overexpressing a pathogenic htt exon 1 protein, photoreceptor degeneration and motor function improved. These results indicate that modulators of htt exon 1 misfolding and oligomerization like EGCG are likely to reduce polyQ-mediated toxicity in vivo. Our studies may provide the basis for the development of a novel pharmacotherapy for HD and related polyQ disorders.
Similar articles
-
Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.Proc Natl Acad Sci U S A. 2004 Dec 21;101(51):17616-21. doi: 10.1073/pnas.0408134101. Epub 2004 Dec 14. Proc Natl Acad Sci U S A. 2004. PMID: 15598740 Free PMC article.
-
Aggregation in Huntington's disease: insights through modelling.Genome Inform. 2005;16(1):262-71. Genome Inform. 2005. PMID: 16362929
-
The P42 peptide and Peptide-based therapies for Huntington's disease.Orphanet J Rare Dis. 2016 Mar 17;11:24. doi: 10.1186/s13023-016-0405-3. Orphanet J Rare Dis. 2016. PMID: 26984770 Free PMC article. Review.
-
Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.J Biol Chem. 2003 Oct 17;278(42):41452-61. doi: 10.1074/jbc.M303354200. Epub 2003 Jul 29. J Biol Chem. 2003. PMID: 12888569
-
Huntington's Disease.Cold Spring Harb Perspect Biol. 2011 Jun 1;3(6):a007476. doi: 10.1101/cshperspect.a007476. Cold Spring Harb Perspect Biol. 2011. PMID: 21441583 Free PMC article. Review.
Cited by
-
Inositol 1,4,5-tripshosphate receptor, calcium signaling, and polyglutamine expansion disorders.Curr Top Membr. 2010;66:323-41. doi: 10.1016/S1063-5823(10)66014-0. Epub 2010 Jul 25. Curr Top Membr. 2010. PMID: 22353486 Free PMC article.
-
Green Tea Epigallocatechin-3-gallate (EGCG) _targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.Biomolecules. 2021 May 20;11(5):767. doi: 10.3390/biom11050767. Biomolecules. 2021. PMID: 34065606 Free PMC article. Review.
-
Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases.Neurotherapeutics. 2013 Jul;10(3):440-6. doi: 10.1007/s13311-013-0184-7. Neurotherapeutics. 2013. PMID: 23504628 Free PMC article. Review.
-
Mechanisms of copper ion mediated Huntington's disease progression.PLoS One. 2007 Mar 28;2(3):e334. doi: 10.1371/journal.pone.0000334. PLoS One. 2007. PMID: 17396163 Free PMC article.
-
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics.Front Neurosci. 2023 Jan 9;16:1084493. doi: 10.3389/fnins.2022.1084493. eCollection 2022. Front Neurosci. 2023. PMID: 36699535 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases